Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028521588> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W2028521588 endingPage "347" @default.
- W2028521588 startingPage "340" @default.
- W2028521588 abstract "A series of 23 monoclonal antibodies reactive with normal lymphoid and myeloid cells at various stages of differentiation were used to characterize 96 adult patients with acute myelocytic leukaemia (AML), concentrating on the possible role the expression of these antigens may have in predicting response to intensive chemotherapy. Only the expression of CD34 (P = 0.008) and HLA-DR (P = 0.035) was significant in predicting response to therapy; patients with leukaemic cells expressing CD34 (My10) had a complete remission (CR) rate of 59% compared to 87% for those with blasts not expressing the antigen. In a multivariate analysis predicting for CR, the expression of CD34, the disease category (de novo AML versus secondary AML [SAML] or a history of antecedent haematological disorder [AHD]), and WBC were significant covariates. Adjusting for disease category and WBC, patients with CD34-positive AML were one-third as likely to enter CR as with those with disease not expressing the antigen (P = 0.066). Comparison of clinical characteristics between the 58 patients whose leukaemia expressed CD34 and the 33 which were CD34-negative found that patients with CD34-positive AML had a higher incidence of SAML and AHD, a lower WBC at diagnosis, and a more frequent incidence of chromosomal abnormalities involving chromosomes 5 and/or 7. Twenty-eight of these patients also had immunophenotyping performed at relapse. Patients who presented with CD34-positive AML, and entered remission, and then relapsed all recurred with CD34-positive leukaemia; there was no case of CD34-positive AML at diagnosis relapsing with CD34-negative disease. In addition, there were patients presenting with CD34-negative AML and then relapsing with CD34-positive AML. These results suggest that intensive cytoreductive therapy is ineffective against CD34-positive AML. Patients who present with CD34-positive AML may require different therapeutic approaches to completely eradicate their disease." @default.
- W2028521588 created "2016-06-24" @default.
- W2028521588 creator A5021230880 @default.
- W2028521588 creator A5040758762 @default.
- W2028521588 creator A5047214928 @default.
- W2028521588 creator A5052878727 @default.
- W2028521588 creator A5060234674 @default.
- W2028521588 creator A5081765963 @default.
- W2028521588 creator A5087391729 @default.
- W2028521588 date "1990-11-01" @default.
- W2028521588 modified "2023-10-16" @default.
- W2028521588 title "Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My 10)" @default.
- W2028521588 cites W113943006 @default.
- W2028521588 cites W1503883962 @default.
- W2028521588 cites W1965686689 @default.
- W2028521588 cites W2028944492 @default.
- W2028521588 cites W2042021736 @default.
- W2028521588 cites W2150113701 @default.
- W2028521588 cites W2167166475 @default.
- W2028521588 cites W2266287318 @default.
- W2028521588 cites W2266306026 @default.
- W2028521588 cites W2313410650 @default.
- W2028521588 cites W2396527347 @default.
- W2028521588 cites W2462871550 @default.
- W2028521588 cites W3041047318 @default.
- W2028521588 cites W4233303333 @default.
- W2028521588 doi "https://doi.org/10.1111/j.1365-2141.1990.tb06365.x" @default.
- W2028521588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1702006" @default.
- W2028521588 hasPublicationYear "1990" @default.
- W2028521588 type Work @default.
- W2028521588 sameAs 2028521588 @default.
- W2028521588 citedByCount "180" @default.
- W2028521588 countsByYear W20285215882012 @default.
- W2028521588 countsByYear W20285215882013 @default.
- W2028521588 countsByYear W20285215882014 @default.
- W2028521588 countsByYear W20285215882015 @default.
- W2028521588 countsByYear W20285215882016 @default.
- W2028521588 countsByYear W20285215882017 @default.
- W2028521588 countsByYear W20285215882019 @default.
- W2028521588 countsByYear W20285215882022 @default.
- W2028521588 crossrefType "journal-article" @default.
- W2028521588 hasAuthorship W2028521588A5021230880 @default.
- W2028521588 hasAuthorship W2028521588A5040758762 @default.
- W2028521588 hasAuthorship W2028521588A5047214928 @default.
- W2028521588 hasAuthorship W2028521588A5052878727 @default.
- W2028521588 hasAuthorship W2028521588A5060234674 @default.
- W2028521588 hasAuthorship W2028521588A5081765963 @default.
- W2028521588 hasAuthorship W2028521588A5087391729 @default.
- W2028521588 hasConcept C10205521 @default.
- W2028521588 hasConcept C126322002 @default.
- W2028521588 hasConcept C142724271 @default.
- W2028521588 hasConcept C143998085 @default.
- W2028521588 hasConcept C147483822 @default.
- W2028521588 hasConcept C196166836 @default.
- W2028521588 hasConcept C203014093 @default.
- W2028521588 hasConcept C2779282312 @default.
- W2028521588 hasConcept C28328180 @default.
- W2028521588 hasConcept C54355233 @default.
- W2028521588 hasConcept C71924100 @default.
- W2028521588 hasConcept C86803240 @default.
- W2028521588 hasConceptScore W2028521588C10205521 @default.
- W2028521588 hasConceptScore W2028521588C126322002 @default.
- W2028521588 hasConceptScore W2028521588C142724271 @default.
- W2028521588 hasConceptScore W2028521588C143998085 @default.
- W2028521588 hasConceptScore W2028521588C147483822 @default.
- W2028521588 hasConceptScore W2028521588C196166836 @default.
- W2028521588 hasConceptScore W2028521588C203014093 @default.
- W2028521588 hasConceptScore W2028521588C2779282312 @default.
- W2028521588 hasConceptScore W2028521588C28328180 @default.
- W2028521588 hasConceptScore W2028521588C54355233 @default.
- W2028521588 hasConceptScore W2028521588C71924100 @default.
- W2028521588 hasConceptScore W2028521588C86803240 @default.
- W2028521588 hasIssue "3" @default.
- W2028521588 hasLocation W20285215881 @default.
- W2028521588 hasLocation W20285215882 @default.
- W2028521588 hasOpenAccess W2028521588 @default.
- W2028521588 hasPrimaryLocation W20285215881 @default.
- W2028521588 hasRelatedWork W2041867129 @default.
- W2028521588 hasRelatedWork W2114998031 @default.
- W2028521588 hasRelatedWork W2278528399 @default.
- W2028521588 hasRelatedWork W2357642474 @default.
- W2028521588 hasRelatedWork W2371090078 @default.
- W2028521588 hasRelatedWork W2402352172 @default.
- W2028521588 hasRelatedWork W2581178810 @default.
- W2028521588 hasRelatedWork W3101656339 @default.
- W2028521588 hasRelatedWork W3161581821 @default.
- W2028521588 hasRelatedWork W4220748641 @default.
- W2028521588 hasVolume "76" @default.
- W2028521588 isParatext "false" @default.
- W2028521588 isRetracted "false" @default.
- W2028521588 magId "2028521588" @default.
- W2028521588 workType "article" @default.